No Safety Concern for Accidental High-Dose Flu Vaccine in Patients Under 65
If a patient under 65 accidentally receives the high-dose influenza vaccine, there is no significant safety concern, and no corrective action is needed. The vaccine can be counted as a valid dose.
Key Points from Guidelines
The ACIP guidelines explicitly address this scenario. When a vaccine formulation approved for adult use is inadvertently administered to someone outside the approved age range, it should still be counted as a single valid dose 1. This guidance applies to the high-dose vaccine (HD-IIV3) given to patients under 65.
Why This Is Not a Problem
The high-dose vaccine contains 60 μg of hemagglutinin (HA) per virus strain (180 μg total), which is four times the standard dose of 15 μg per strain 1. While this formulation is FDA-approved only for adults ≥65 years, the higher antigen content does not create safety issues in younger adults—it simply provides more antigen than necessary.
Safety Evidence
Real-world data supports the safety of off-label use:
- Approximately 36,624 off-label high-dose vaccines were administered to adults under 65 between 2010-2012, with half given to patients aged 50-64 years 2
- These patients often had chronic comorbidities, suggesting physicians sometimes intentionally used HD vaccine in higher-risk younger adults 2
- No unique safety signals emerged from this off-label use 2
The safety profile of HD vaccine shows:
- Higher rates of local reactions (pain, swelling, induration) and systemic effects (headache, chills, malaise) compared to standard-dose vaccine 3
- These are mild, self-limited adverse events consistent with the higher antigen load 4, 5
- No serious safety concerns identified in postmarketing surveillance 4
Clinical Recommendation
Do not revaccinate the patient. The accidentally administered high-dose vaccine provides adequate—likely enhanced—protection against influenza. The patient may experience slightly more injection site soreness or systemic symptoms than with standard-dose vaccine, but these are temporary and not medically concerning.
Important Caveat
The one exception where HD vaccine should NOT be used is in solid organ transplant recipients aged 18-64 on immunosuppressive regimens, where HD-IIV3 is actually an acceptable option without preference over standard vaccines 6, 1. This represents intentional use rather than an error.
Documentation
Document the vaccine administration error in the medical record, note that the dose counts toward influenza vaccination requirements for the season, and inform the patient that no additional action is needed 1.